Company Filing History:
Years Active: 2010-2012
Title: Sally Walsh: Innovator in Pharmaceutical Chemistry
Introduction
Sally Walsh is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that enhance metabotropic glutamate receptors. With a total of 4 patents to her name, her work has the potential to impact therapeutic applications significantly.
Latest Patents
Sally Walsh's latest patents include innovative compounds such as metabotropic glutamate-receptor-potentiating isoindolones. These compounds are defined by specific formulas, wherein R, R, R, R, R, R, R, R, and n are detailed in the patent description. The patents also cover processes for preparing these compounds, new intermediates used in their preparation, pharmaceutical compositions containing the compounds, and their therapeutic uses. Another notable patent focuses on isoindolone compounds and their application as metabotropic glutamate receptor potentiators, further emphasizing her expertise in this area.
Career Highlights
Sally Walsh is currently associated with AstraZeneca AB, where she continues to advance her research and development efforts. Her work at AstraZeneca has allowed her to collaborate with leading experts in the field, enhancing the impact of her inventions.
Collaborations
Some of her notable coworkers include Bradford C Van Wagenen and Radhakrishnan Ukkiramapandian. Their collaborative efforts contribute to the innovative environment at AstraZeneca, fostering advancements in pharmaceutical research.
Conclusion
Sally Walsh's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a key innovator in the field. Her work continues to pave the way for new therapeutic solutions.